- Oxycodone/paracetamol
-
Percocet Combination of Oxycodone Opioid analgesic Paracetamol Anilide analgesic Clinical data AHFS/Drugs.com monograph Licence data US FDA:link Pregnancy cat. C Legal status Schedule II (US) Routes Oral Identifiers CAS number 330988-72-2 ATC code ? ChemSpider 4881971 (what is this?) (verify) The combination oxycodone/paracetamol (North American trade name of combination Percocet, North American trade name of latter Acetaminophen) is a narcotic pain reliever used to treat moderate to severe acute (short-term) pain, marketed by Endo Pharmaceuticals.[1]
Contents
History
The U.S. Food and Drug Administration first approved Percocet in 1976, under application ANDA 085106.[2]
Formulation
As of March 2006, Endo Pharmaceuticals produces Percocet in following dosages.[3] Percocet tablets are available in six combinations of oxycodone hydrochloride and acetaminophen, with different appearances and maximum daily doses:[3]
Oxycodone Hydrochloride (mg) Acetaminophen (mg) Tablet Color Tablet Shape Maximum Daily Dose 2.5 325 pink oval 12 tablets 5 325 white round 12 tablets 7.5 325 peach oval 8 tablets 7.5 500 peach capsule-shaped 8 tablets 10.0 325 white oblong 6 tablets 10.0 650 yellow oval 6 tablets For the 2.5 mg Oxycodone HCL tablet, the usual dose is 1–2 tablets every six hours as needed for pain; for the other tablets, the usual dose is 1 tablet every six hours as needed for pain.[3]
Use in pain management
This medicine, in recent years, has gained favor among the medical community due to its effectiveness and a lower addiction rate than morphine. It is very useful to give to someone who is experiencing acute severe pain that is neither chronic nor breakthrough.[citation needed]
Implicated in deaths
On June 30, 2009, an FDA advisory panel recommended that Percocet, Vicodin, and every other combination of acetaminophen with narcotic analgesics[4] be removed from the market because of their contributions to an alleged 400 acetaminophen related deaths in the United States each year, that were attributed to acetaminophen overdose and associated liver damage.[5]
In December 2009, the Canadian Medical Association Journal reported a study finding a fivefold increase in oxycodone-related deaths in Ontario (mostly accidental) between 1991 and 2007 that led to a doubling of all opioid-related Ontario deaths over the same period.[6]
References
- ^ http://www.endo.com/pdf/products/Percocet_pack_insert_2.pdf
- ^ "Drugs@FDA. FDA approved drug products (searchable database)". U.S. Food and Drug Administration, Center for Drug Evaluation and Research. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm. Retrieved 2009-03-30.
- ^ a b c "Percocet oxycodone and acetaminophen tablets USP". Endo Pharmaceuticals. 2006 November. http://www.endo.com/pdf/products/Percocet_pack_insert_4.pdf. Retrieved 2009-03-30.
- ^ http://www.webmd.com/pain-management/news/20090701/fda-may-restrict-acetaminophen
- ^ Harris, Gardiner (2009-07-01). "Ban Is Advised on 2 Top Pills for Pain Relief". The New York Times. http://www.nytimes.com/2009/07/01/health/01fda.html?em. Retrieved 2010-05-22.
- ^ sciencedaily.com
External links
This analgesic-related article is a stub. You can help Wikipedia by expanding it.